Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 21.09 % in the past year, substantial increase in net sales/revenue by 202.68 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -20.23 %, Marginal increase in other income during this quarter, up by 125.27%.
- Profit over the Year and quarter: Challenges in sustaining profitability for ASTEC LIFESCIENCES LIMITED. Profit dropped by -80.62 % Year to Year, ASTEC LIFESCIENCES LIMITED’s profitability dropped by -96.04 % Quarter to Quarter.
- EPS over the Year and quarter: EPS declined by -119.69 % Year to Year. EPS decreased by -104.03 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 126.972 Cr | Rs. 50.795 Cr | Rs. 153.748 Cr | + 202.68 % | + 21.09 % |
| Expenses | Rs. 121.57 Cr | Rs. 69.12 Cr | Rs. 141.04 Cr | + 104.05 % | + 16.02 % |
| Operating Profit | Rs. 5.4 Cr | Rs. -18.33 Cr | Rs. 12.71 Cr | + 169.34 % | + 135.37 % |
| OPM % | 4.25 % | -36.09 % | 8.27 % | + 44.36 % | + 4.02 % |
| Other Income | Rs. 2.57 Cr | Rs. 0.91 Cr | Rs. 2.05 Cr | + 125.27 % | -20.23 % |
| Interest | Rs. 6.4 Cr | Rs. 6.1 Cr | Rs. 6.68 Cr | + 9.51 % | + 4.37 % |
| Depreciation | Rs. 7.76 Cr | Rs. 8.7 Cr | Rs. 9.01 Cr | + 3.56 % | + 16.11 % |
| Profit before tax | Rs. -6.19 Cr | Rs. -32.22 Cr | Rs. -0.93 Cr | + 97.11 % | + 84.98 % |
| Tax % | -19.54 % | -24.5 % | -4.1 % | + 20.4 % | + 15.44 % |
| Net Profit | Rs. -4.98 Cr | Rs. -24.33 Cr | Rs. -0.96 Cr | + 96.05 % | + 80.72 % |
| EPS in Rs | Rs. -2.54 | Rs. -12.41 | Rs. 0.5 | + 104.03 % | + 119.69 % |
Today, we’re looking at ASTEC LIFESCIENCES LIMITED’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 21.09 %. However, it did see a marginal increase of 202.68 % from the previous quarter. Expenses ticked up slightly by 104.05 % quarter-on-quarter, aligning with the annual rise of 16.02 %. Operating profit, while up 135.37 % compared to last year, faced a quarter-on-quarter increase of 169.34 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 4.02 %, but an expansion of 44.36 % sequentially. Other income rose by 125.27 % compared to the last quarter, despite an annual decline of -20.23 %. Interest expenses surged remarkably by 9.51 % from the previous quarter, yet the year-over-year increase remains at a moderate 4.37 %. Depreciation costs climbed by 3.56 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 16.11 %. Profit before tax grew annually by 84.98 % but saw an increase from the preceding quarter by 97.11 %.
Tax expenses as a percentage of profits increased slightly by 15.44 % compared to last year, with a more notable quarter-on-quarter increase of 20.4 %. Net profit rose by 80.72 % year-on-year but experienced a 96.05 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 119.69 % but a quarterly rise of 104.03 %. In summary, ASTEC LIFESCIENCES LIMITED’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 126.972 Cr | Rs. 50.795 Cr | Rs. 153.748 Cr | + 202.68 % | + 21.09 % |
| Expenses | Rs. 121.57 Cr | Rs. 69.12 Cr | Rs. 141.04 Cr | + 104.05 % | + 16.02 % |
| Operating Profit | Rs. 5.4 Cr | Rs. -18.33 Cr | Rs. 12.71 Cr | + 169.34 % | + 135.37 % |
| Net Profit | Rs. -4.98 Cr | Rs. -24.33 Cr | Rs. -0.96 Cr | + 96.05 % | + 80.72 % |
| EPS in Rs | Rs. -2.54 | Rs. -12.41 | Rs. 0.5 | + 104.03 % | + 119.69 % |
In reviewing ASTEC LIFESCIENCES LIMITED’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 21.09 % year-on-year growth, however, there was a minor increase of 202.68 % from the previous quarter. Expenses rose by 16.02 % compared to the previous year, with a 104.05 % increase quarter-on-quarter. Operating Profit surged by 135.37 % annually, and saw a 169.34 % increase from the last quarter.
Net Profit showed yearly increase of 80.72 %, and experienced a 96.05 % increase from the previous quarter. Earnings Per Share (EPS) rose by 119.69 % annually, however rose by 104.03 % compared to the last quarter. In essence, while ASTEC LIFESCIENCES LIMITED exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
